Consult
Log In
Menu
Consult
Log in

by PierianDx, on March 22, 2021

According to recent estimates, almost 80% of cancer patients (1,2) in the United States are diagnosed and treated in community cancer centers. With incredibly busy schedules, providers at these centers often struggle to offer to most up-to-date, cutting edge care.

Read Story
Topics:Blog

by PierianDx, on March 2, 2021

ST. LOUIS, MO., March 2, 2021 — PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of clinical genomics solutions in the fight against cancer and hereditary disease. She will also head the company’s life sciences efforts, establishing key alliances with industry partners and biopharmaceutical companies that will ultimately provide broader access to genomic testing and precision medicine-based treatments for patients.

Read Story